Carna Biosciences (TSE:4572) Total Stockholders Equity : 円3,215 Mil (As of Jun. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Carna Biosciences Total Stockholders Equity?

Carna Biosciences's Total Stockholders Equity for the quarter that ended in Jun. 2024 was 円3,215 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Carna Biosciences's Book Value per Share for the quarter that ended in Jun. 2024 was 円178.16. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Carna Biosciences's Debt-to-Equity for the quarter that ended in Jun. 2024 was 0.03.

Carna Biosciences Total Stockholders Equity Historical Data

The historical data trend for Carna Biosciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carna Biosciences Total Stockholders Equity Chart

Carna Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

3,853.52

3,824.01

4,315.57

3,641.85

3,877.54

Carna Biosciences Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Total Stockholders Equity	Get a 7-Day Free Trial															4,111.80	3,816.62	3,877.54	3,517.97	3,215.32

Carna Biosciences (TSE:4572) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Carna Biosciences's Book Value per Share for the quarter that ended in Jun. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(3215.316	-	0)	/	18.0478
	=	178.16

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Carna Biosciences's Debt-to-Equity for the quarter that ended in Jun. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(70.002	+	18.406)	/	3215.316
	=	0.03

Carna Biosciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Carna Biosciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Carna Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Carna Biosciences Inc (TSE:4572) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

BMA 3F 1-5-5 Minatojima-Minamimachi, Kobe, JPN, 650-0047

Website

http://www.carnabio.com

Carna Biosciences Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines for the treatment of cancer and inflammatory diseases using own kinase drug discovery platform, QuickScout.

Carna Biosciences Headlines

No Headlines